Buluo Fenhuan Shihun Xuanye (布洛芬缓释混悬液)布洛芬缓释混悬液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

布洛芬是一种在国家药监局注册认定的药品。该药品含有布洛芬-14489b9d等成分。

该药品关联的活性成分包括:布洛芬ibuprofen。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:四川中方制药有限公司Chinese legal name: 四川中方制药有限公司。

您可以探索含有相同成分的其他药品:布洛芬-14489b9d成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

ibuprofen is a medicine registered with the national drug regulatory authority. It contains ibuprofen as active ingredient(s).

Active ingredients associated with this product: ibuprofenibuprofen.

Manufacturers recorded for this product: 四川中方制药有限公司Chinese legal name: 四川中方制药有限公司.

Explore other medicines containing the same ingredient: ibuprofen products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 布洛芬缓释混悬液Recorded Chinese name: 布洛芬缓释混悬液
  • 规格Specification: 60ml60 mL

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 四川中方制药有限公司Chinese legal name: 四川中方制药有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20000531

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20000531

Manufacturer

Chinese legal name: 四川中方制药有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20000531

生产企业

四川中方制药有限公司(国产)

适应症

本品系非甾体类抗炎药,有解热,镇痛及抗炎作用,适用于:|1. 由感冒、急性上呼吸道感染、急性咽喉炎等疾病引起的发热。|2. 可用于减轻或消除以下疾病的疼痛或炎症:|(1) 扭伤、劳损、肩周炎、滑囊炎、肌腱炎,旋转带肌腱炎及腱鞘炎。|(2) 痛经、牙痛、术后疼痛及腰部疼痛。|(3) 类风湿性关节炎、骨关节炎、其它非类风湿性关节炎及急性痛风。

用法用量

口服:|1. 成人及12岁以上儿童:推荐剂量为一次0. 3~0. 6g(10~20ml),一日2次,或遵医嘱。|2. 1岁~12岁儿童患者:|(1) 用于发热,推荐剂量为每日按体重20mg/kg(0. 66ml),分2次服用,或遵医嘱。|(2) 用于镇痛,推荐剂量为每日按体重30mg/kg(1ml),分2次服用,或遵医嘱。

不良反应

本品耐受性好,副作用低,一般为肠、胃部不适或皮疹、头痛、耳鸣。

禁忌

1. 活动期消化道溃疡者。|2. 对本药物过敏者;曾有因服用阿司匹林和其它非类固醇类抗炎药诱发哮喘、鼻炎或荨麻疹病史的患者。

注意事项

1. 肠胃病患者慎用。|2. 有支气管哮喘病史患者,可能会引起支气管痉挛。|3. 并用抗凝血剂的患者,服药的最初几日应随时监测其凝血酶原时间。|4. 心功能不全及原发性高血压病患者慎用。|5. 连续服用3天发热不退时,应请医生诊治。

贮藏

密闭。

规格

60ml

证据Evidence

  • 批准文号: 国药准字H20000531
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.